Jennifer K. Maratt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jennifer K. Maratt has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Sameer D. Saini
Veterans Affairs Ann Arbor Healthcare System Ann Arbor MI USA
3 shared publicationsStacy B. Menees
Veterans Affairs Ann Arbor Healthcare System Ann Arbor MI USA
2 shared publications- Stacy Bartnik Menees
University of Michigan 3 Division of Gastroenterology, Department of Internal Medicine Ann Arbor, Michigan
2 shared publications Thomas F. Imperiale
Indiana University School of Medicine, Indianapolis
2 shared publications- Vipul Jairath
Division of Gastroenterology, Western University, London, Ontario, Canada
2 shared publications Akbar K. Waljee
Veterans Affairs Ann Arbor Healthcare System Ann Arbor MI USA
1 shared publication
Latest Publications
- 8 January 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (6) , 1326-1338
Adenomatous Polyposis Coli Gene Polyposis-Related Syndromes
Gastrointestinal cancers, particularly those of the stomach and colorectum, are among the leading causes of cancer-related morbidity and mortality in the United States and worldwide. The adenomatous polyposis coli ( APC ) gene functions as a tumor suppressor gene whose loss of function plays a critical role in gastrointestinal cancer development. Pathogenic/likely pathogenic variants of the APC gene are associated with intestinal (gastric, small bowel, and colorectal neoplasia) and extra-intestinal manifestations. In this narrative review, we discuss the epidemiology, diagnosis, and management of APC gene-related polyposis syndromes. We also review the variation in genotype-phenotype presentations and discuss practical aspects of caring for individuals affected by these syndromes with an emphasis on multidisciplinary care, family planning, and transitions of care.
- 8 January 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (6) , 1326-1338
Adenomatous Polyposis Coli Gene Polyposis-Related Syndromes
Gastrointestinal cancers, particularly those of the stomach and colorectum, are among the leading causes of cancer-related morbidity and mortality in the United States and worldwide. The adenomatous polyposis coli ( APC ) gene functions as a tumor suppressor gene whose loss of function plays a critical role in gastrointestinal cancer development. Pathogenic/likely pathogenic variants of the APC gene are associated with intestinal (gastric, small bowel, and colorectal neoplasia) and extra-intestinal manifestations. In this narrative review, we discuss the epidemiology, diagnosis, and management of APC gene-related polyposis syndromes. We also review the variation in genotype-phenotype presentations and discuss practical aspects of caring for individuals affected by these syndromes with an emphasis on multidisciplinary care, family planning, and transitions of care.
- Open Access
- 11 August 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 60 (8) , 1042-1050
Performance of bowel preparation quality scales in patients with Crohn's disease
Summary: Background: The performance of bowel preparation (BP) in patients with Crohn's disease (CD) is unknown.Aims: To evaluate the operating properties of instruments used to assess BP quality in patients with CD.Methods: We used the Boston Bowel Preparation Scale, modified Boston Bowel Preparation Scale, Harefield Cleansing Scale, Food and Drug Administration Bowel Cleansing Assessment Scale (BCAS), and a 100‐mm visual analogue scale of bowel cleanliness to assess BP quality in 50 videos from 40 patients with CD. We assessed endoscopic activity with the Simple Endoscopic Score for CD (SES‐CD). Assessments were on endoscope insertion and withdrawal. Reliability was quantified using the intraclass correlation coefficient (ICC). We assessed validity by within‐patient correlation between instruments and the visual analogue scale using mixed‐effect models. The correlation between BP quality and SES‐SD scores was assessed using Spearman's rho.Results: Inter‐ and intra‐rater reliability for all BP quality instruments was substantial (ICC ≥0.61) except for the Food and Drug Administration BCAS on insertion (inter‐rater reliability ICC ≥0.41). The visual analogue scale had substantial inter‐ and almost perfect (ICC ≥0.81) intra‐rater reliability. Correlation coefficients for the validity of the instruments exceeded 0.58. BP quality and endoscopic disease activity scores in the colon were negatively correlated.Conclusion: Most existing instruments reliably assess BP quality in patients with CD. These results support the use of these instruments in clinical practice, provide a framework for scoring BP quality in CD clinical trials, and support evaluation of novel BP agents in patients with CD.
- 11 August 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 60 (8) , 1042-1050
Open AccessPerformance of bowel preparation quality scales in patients with Crohn's disease
Summary: Background: The performance of bowel preparation (BP) in patients with Crohn's disease (CD) is unknown.Aims: To evaluate the operating properties of instruments used to assess BP quality in patients with CD.Methods: We used the Boston Bowel Preparation Scale, modified Boston Bowel Preparation Scale, Harefield Cleansing Scale, Food and Drug Administration Bowel Cleansing Assessment Scale (BCAS), and a 100‐mm visual analogue scale of bowel cleanliness to assess BP quality in 50 videos from 40 patients with CD. We assessed endoscopic activity with the Simple Endoscopic Score for CD (SES‐CD). Assessments were on endoscope insertion and withdrawal. Reliability was quantified using the intraclass correlation coefficient (ICC). We assessed validity by within‐patient correlation between instruments and the visual analogue scale using mixed‐effect models. The correlation between BP quality and SES‐SD scores was assessed using Spearman's rho.Results: Inter‐ and intra‐rater reliability for all BP quality instruments was substantial (ICC ≥0.61) except for the Food and Drug Administration BCAS on insertion (inter‐rater reliability ICC ≥0.41). The visual analogue scale had substantial inter‐ and almost perfect (ICC ≥0.81) intra‐rater reliability. Correlation coefficients for the validity of the instruments exceeded 0.58. BP quality and endoscopic disease activity scores in the colon were negatively correlated.Conclusion: Most existing instruments reliably assess BP quality in patients with CD. These results support the use of these instruments in clinical practice, provide a framework for scoring BP quality in CD clinical trials, and support evaluation of novel BP agents in patients with CD.
- 4 March 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e242652
Closing a Gap in Colorectal Cancer Screening
Colorectal cancer (CRC) is one of the most prevalent, but highly preventable, cancers in the US. Much progress has been made in reducing CRC incidence and
- 4 March 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e242652
Closing a Gap in Colorectal Cancer Screening
Colorectal cancer (CRC) is one of the most prevalent, but highly preventable, cancers in the US. Much progress has been made in reducing CRC incidence and
- 27 November 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (5) , 1718-1727
An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn’s Disease
Background Despite regular need for colonoscopy in patients with Crohn’s disease (CD), the efficacy and tolerability of bowel preparation (BP) agents is rarely assessed in this population. Assessing BP quality with existing scales may be challenging in CD due to presence of inflammation, bowel resection, and strictures. Aims To provide recommendations for assessing BP quality in clinical trials for CD using a modified Research and Development/University of California, Los Angeles appropriateness process. Methods Based on systematic reviews and a literature search, 110 statements relating to BP quality assessment in CD were developed. A panel of 15 gastroenterologists rated the statements as appropriate, uncertain, or inappropriate using a 9-point Likert scale. Results Panelists considered it appropriate that central readers, either alone or with local assessment, score BP quality in clinical trials. Central readers should be trained on scoring BP quality and local endoscopists on performing high-quality video recording. Both endoscope insertion and withdrawal phases should be reviewed to score BP quality in each colonic segment and segments should align with endoscopic disease activity indices. The Harefield Cleansing Scale and the Boston Bowel Preparation Scale were considered appropriate. The final score should be calculated as the average of all visualized segments. Both total and worst segment scores should also be assessed. Conclusions We developed a framework for assessing BP quality in patients with CD based on expert feedback. This framework could support the development or refinement of BP quality scales and the integration of BP quality assessment in future CD studies.
- 27 November 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (5) , 1718-1727
An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn’s Disease
Background Despite regular need for colonoscopy in patients with Crohn’s disease (CD), the efficacy and tolerability of bowel preparation (BP) agents is rarely assessed in this population. Assessing BP quality with existing scales may be challenging in CD due to presence of inflammation, bowel resection, and strictures. Aims To provide recommendations for assessing BP quality in clinical trials for CD using a modified Research and Development/University of California, Los Angeles appropriateness process. Methods Based on systematic reviews and a literature search, 110 statements relating to BP quality assessment in CD were developed. A panel of 15 gastroenterologists rated the statements as appropriate, uncertain, or inappropriate using a 9-point Likert scale. Results Panelists considered it appropriate that central readers, either alone or with local assessment, score BP quality in clinical trials. Central readers should be trained on scoring BP quality and local endoscopists on performing high-quality video recording. Both endoscope insertion and withdrawal phases should be reviewed to score BP quality in each colonic segment and segments should align with endoscopic disease activity indices. The Harefield Cleansing Scale and the Boston Bowel Preparation Scale were considered appropriate. The final score should be calculated as the average of all visualized segments. Both total and worst segment scores should also be assessed. Conclusions We developed a framework for assessing BP quality in patients with CD based on expert feedback. This framework could support the development or refinement of BP quality scales and the integration of BP quality assessment in future CD studies.
- 2 September 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 136 (3) , 308-314.e3
Using Online Colorectal Cancer Risk Calculators to Guide Screening Decision-Making
- 2 September 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 136 (3) , 308-314.e3
Using Online Colorectal Cancer Risk Calculators to Guide Screening Decision-Making
- 13 March 2022
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 24 (4) , 381-389
Quality Assurance in Pre-Endoscopic Evaluation
- 13 March 2022
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 24 (4) , 381-389
Quality Assurance in Pre-Endoscopic Evaluation
- 1 January 2022
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 32 (1) , 45-58
Identification of Lynch Syndrome
- 1 January 2022
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 32 (1) , 45-58
Identification of Lynch Syndrome
- Open Access
- 14 December 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (1) , 133-134
Editorial: sporadic early‐onset colorectal cancer—appreciating aetiologic complexity
LINKED CONTENT: This article is linked to Vuik et al papers. To view these articles, visit https://doi.org/10.1111/apt.16638
- 14 December 2021
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (1) , 133-134
Open AccessEditorial: sporadic early‐onset colorectal cancer—appreciating aetiologic complexity
LINKED CONTENT: This article is linked to Vuik et al papers. To view these articles, visit https://doi.org/10.1111/apt.16638
- 3 April 2020
- Published by Springer Nature
- p. 81-101
Familial Adenomatous Polyposis: Management of Upper Gastrointestinal Polyps
- 3 April 2020
- Published by Springer Nature
- p. 81-101
Familial Adenomatous Polyposis: Management of Upper Gastrointestinal Polyps